Tazemetostat
Drug timelines are a Plus or Pro feature.
22 regulatory and trial events tracked for Tazemetostat, covering 2021-04-09 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. [Phase 3]